A detailed history of Squarepoint Ops LLC transactions in Omeros Corp stock. As of the latest transaction made, Squarepoint Ops LLC holds 47,364 shares of OMER stock, worth $530,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,364
Holding current value
$530,950
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.54 - $5.47 $167,668 - $259,081
47,364 New
47,364 $188,000
Q4 2023

Feb 14, 2024

BUY
$1.08 - $3.63 $8,456 - $28,422
7,830 Added 26.38%
37,512 $122,000
Q2 2023

Aug 14, 2023

SELL
$4.45 - $7.57 $264,748 - $450,369
-59,494 Reduced 66.72%
29,682 $161,000
Q1 2023

May 15, 2023

BUY
$2.48 - $5.22 $221,156 - $465,498
89,176 New
89,176 $414,000
Q2 2022

Aug 15, 2022

BUY
$1.92 - $6.28 $75,219 - $246,031
39,177 New
39,177 $108,000
Q1 2022

May 16, 2022

SELL
$5.07 - $7.2 $101,202 - $143,719
-19,961 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$5.67 - $8.54 $113,178 - $170,466
19,961 New
19,961 $128,000
Q3 2021

Nov 15, 2021

SELL
$13.4 - $16.3 $252,683 - $307,369
-18,857 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$14.81 - $19.13 $279,272 - $360,734
18,857 New
18,857 $280,000
Q1 2021

May 17, 2021

SELL
$14.52 - $23.53 $456,407 - $739,618
-31,433 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$10.14 - $15.19 $141,534 - $212,022
-13,958 Reduced 30.75%
31,433 $449,000
Q3 2020

Nov 16, 2020

BUY
$9.57 - $21.32 $434,391 - $967,736
45,391 New
45,391 $459,000
Q2 2020

Aug 14, 2020

SELL
$12.21 - $16.99 $818,387 - $1.14 Million
-67,026 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$9.03 - $19.72 $389,193 - $849,932
43,100 Added 180.14%
67,026 $896,000
Q4 2019

Feb 14, 2020

BUY
$13.01 - $17.15 $140,156 - $184,756
10,773 Added 81.91%
23,926 $337,000
Q3 2019

Nov 14, 2019

BUY
$14.55 - $20.56 $191,376 - $270,425
13,153 New
13,153 $215,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $703M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.